Significantly reduced abilities to cross-neutralize SARS-CoV-2 variants by sera from convalescent COVID-19 patients infected by Delta or early strains.

ABSTRACT:

SUBMITTER: Pan T 

PROVIDER: S-EPMC8503867 | biostudies-literature | 2021 Nov

REPOSITORIES: biostudies-literature